<DOC>
	<DOCNO>NCT00642642</DOCNO>
	<brief_summary>The purpose study evaluate safety profile treatment effect Isolagen TherapyTM placebo administer facial acne scar .</brief_summary>
	<brief_title>Safety Efficacy Study Autologous Fibroblasts Treatment Severe Facial Acne Scarring</brief_title>
	<detailed_description />
	<mesh_term>Cicatrix</mesh_term>
	<criteria>1 . Male female , 18 year 65 year age . 2 . Investigator assessment acne scar cheek moderate severe . 3 . A history acne scar 3 year . 4 . Subject assess appearance side facial acne scar dissatisfy dissatisfied appearance . 1 . Significant active acne . 2 . Use oral antibiotic retinoid active acne therapy within one year enrollment . 3 . Presence hypertrophic scar cheek . 4 . More 20 % treatment area comprise ice pick scar sinus tracts 5 . Treatment area per cheek le 9 cm x cm 6 . Unilateral unbalance acne scar distribution . 7 . Physical attribute prevent assessment treatment acne scar . 8 . Treatment investigational product procedure within 30 day prior study enrollment plan participate another clinical trial course study . 9 . Previous treatment Isolagen TherapyTM . 10 . Use Isotretinoin within one year enrollment study . 11 . Use permanent semipermanent dermal filler treatment area within defined time frame . 12 . Disorders drug increase bleed clot . 13 . Pregnant lactate woman woman try become pregnant study . 14 . Excessive exposure sun . 15 . Smoking Â½ pack cigarette per day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Acne</keyword>
</DOC>